Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Expanded access study confirms the long-acting monoclonal antibody works well in people with extensive prior treatment.
Federal researchers describe two paths to a vaccine—and one of them uses high-tech computers to design a vaccine candidate!
A series of antibody infusions suppressed HIV for up to four months without prompting the virus to develop resistance.
Antibodies protect monkeys against SHIV.
With an FDA decision for ibalizumab pending, data about a group with multidrug resistance show that the antibody is effective.
TaiMed Biologics has applied for approval of the weekly injectable antibody ibalizumab for those with multidrug-resistant virus.
Researchers have found a new broadly neutralizing antibody against HIV. It is said to be safe, well tolerated and potent.
Scientists have discovered a powerful antibody against HIV that neutralizes 98 percent of the types of virus they tested it against...
The injectable long-acting antibody against HIV ibalizumab has shown promise in a trial of people with virus that’s resistant to multiple...
An experimental antibody treatment has led a group of monkeys infected with HIV’s simian cousin into an extended period of viral remission.
Immunotherapy and an HIV vaccine are among the first round of grants from Fred Hutch’s Evergreen Fund.
A cure and a vaccine are topics of research supported by the 2016 Mathilde Krim Fellowships.
A new rapid test that can detect both HIV-1 and HIV-2 antibodies as well as a key antigen is now available for use in health care settings.
A new, more sensitive HIV test uses microspheres to capture antibodies indicating infection.
A new type of HIV test uses microspheres to capture antibodies that indicate an infection and is more accurate in detecting smaller amounts of...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.